Meghan Clowse, M. D.
514: Pregnancy Outcome in Women Exposed to Adalimumab: The OTIS Autoimmune Diseases in Pregnancy Project
513: Pregnancy Outcome in Women Exposed to Leflunomide: The OTIS Autoimmune Diseases in Pregnancy Project
1347: Results of the HepASA Trial: Low Moleculare Weight Heparin + ASA vs ASA Only for Recurrent Pregnancy Loss
550: National Study of Medical Complications in SLE Pregnancies
678: Does Rheumatoid Arthritis Ameliorate During Pregnancy? Results from a Prospective Nationwide Cohort Study (the PARA-study)
1319: Disease Activity and Prednisone Use Influences Birth Weight in Rheumatoid Arthritis Pregnancies
553: Soluble FMS-Like Tyrosine Kinase is a Significant Predictor of Preeclampsia in SLE Pregnancy
All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.
